CA934295A - Vaccine for immunization of poultry against marek's disease - Google Patents

Vaccine for immunization of poultry against marek's disease

Info

Publication number
CA934295A
CA934295A CA100569A CA100569A CA934295A CA 934295 A CA934295 A CA 934295A CA 100569 A CA100569 A CA 100569A CA 100569 A CA100569 A CA 100569A CA 934295 A CA934295 A CA 934295A
Authority
CA
Canada
Prior art keywords
immunization
vaccine
disease
poultry against
against marek
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA100569A
Other languages
English (en)
Inventor
L. Witter Richard
G. Purchase Harvey
Okazaki William
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA934295A publication Critical patent/CA934295A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA100569A 1970-04-29 1970-12-14 Vaccine for immunization of poultry against marek's disease Expired CA934295A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3306070A 1970-04-29 1970-04-29

Publications (1)

Publication Number Publication Date
CA934295A true CA934295A (en) 1973-09-25

Family

ID=21868356

Family Applications (1)

Application Number Title Priority Date Filing Date
CA100569A Expired CA934295A (en) 1970-04-29 1970-12-14 Vaccine for immunization of poultry against marek's disease

Country Status (21)

Country Link
US (1) US3642574A (xx)
JP (1) JPS4841534B1 (xx)
AT (2) AT317606B (xx)
BE (1) BE766492A (xx)
BR (1) BR7102066D0 (xx)
CA (1) CA934295A (xx)
CH (1) CH565863A5 (xx)
CS (1) CS191868B2 (xx)
DE (1) DE2120929B2 (xx)
DK (1) DK133311C (xx)
ES (1) ES390698A1 (xx)
FR (1) FR2092112B1 (xx)
GB (2) GB1316168A (xx)
HU (1) HU162835B (xx)
IE (1) IE35138B1 (xx)
IL (1) IL36329A (xx)
IT (1) IT1045525B (xx)
NL (1) NL165217C (xx)
PL (1) PL76295B1 (xx)
YU (1) YU35785B (xx)
ZA (1) ZA711382B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
US3965258A (en) * 1974-11-30 1976-06-22 Merck & Co., Inc. Process for production of vaccines
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms
NL8401120A (nl) * 1984-04-09 1985-11-01 Centraal Diergeneeskundig Inst Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
JPS6327437A (ja) * 1986-07-17 1988-02-05 Chemo Sero Therapeut Res Inst 鶏伝染病生ワクチン
US5582829A (en) * 1990-04-05 1996-12-10 Rx Technologies, Inc. Sonicated borrelia burgdorferi vaccine
US6303129B1 (en) 1992-07-28 2001-10-16 Rx Technologies Production of borrelia burgdorferi vaccine, product produced thereby and method of use
WO2010008528A2 (en) * 2008-07-18 2010-01-21 The Texas A&M University System Marek's disease virus vaccine compositions and methods of using thereof
AP2014007955A0 (en) 2012-03-22 2014-09-30 Merial Ltd Modified marek's disease virus, and vaccines made therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens

Also Published As

Publication number Publication date
AT317606B (de) 1974-09-10
BE766492A (fr) 1971-09-16
IE35138B1 (en) 1975-11-26
NL165217C (nl) 1981-03-16
GB1317710A (en) 1973-05-23
PL76295B1 (xx) 1975-02-28
HU162835B (xx) 1973-04-28
IL36329A (en) 1975-04-25
NL7100529A (xx) 1971-11-02
FR2092112A1 (xx) 1972-01-21
BR7102066D0 (pt) 1973-03-13
DE2120929A1 (de) 1971-11-18
CS191868B2 (en) 1979-07-31
NL165217B (nl) 1980-10-15
IL36329A0 (en) 1971-05-26
DK133311C (da) 1976-09-20
GB1316168A (en) 1973-05-09
YU35785B (en) 1981-06-30
US3642574A (en) 1972-02-15
JPS4841534B1 (xx) 1973-12-07
CH565863A5 (xx) 1975-08-29
IT1045525B (it) 1980-05-10
AT317421B (de) 1974-08-26
IE35138L (en) 1971-10-29
FR2092112B1 (xx) 1974-09-06
ZA711382B (en) 1972-11-29
YU62571A (en) 1980-10-31
ES390698A1 (es) 1973-07-01
DE2120929B2 (de) 1979-06-28
DK133311B (da) 1976-04-26

Similar Documents

Publication Publication Date Title
CA934295A (en) Vaccine for immunization of poultry against marek's disease
CA934270A (en) Vanne de detente d'un fluide sous pression
CS194154B2 (en) Method of preparing 5-fluor-2-methyl-1-/4'-methyl-sulphinyl-benzylidene/-3-indenylacetic acid
IT942159B (it) Procedimento per la preparazione di 4 ossocapronitrile
NL7409842A (nl) Vaccin tegen de ziekte van marek.
CA922691A (en) Process for the preparation of 21-deoxy-21-n-/n' -methylpiperazinyl/ -prednisolone and salts
IL37656A0 (en) Method and compositions for combatting marek's disease in poultry by the use of diphenyl sulfones and related compounds
AU2793971A (en) Marek's disease inactivated vaccine and process for preparing the same
AU451635B2 (en) Vaccine preparation
IT942666B (it) Procedimento per la preparazione di 5 alchilidenenorbornene 2
IT945954B (it) Procedimento per la preparazione di fenil 1 3 4 ossadiazoli sosti tuiti
AU436023B2 (en) Treatment of marek's disease
IT961214B (it) Procedimento per la preparazione di nitrili 3 4 insaturi
AU463400B2 (en) Poultry vaccine
AU1237170A (en) Treatment of marek's disease
AU2625371A (en) Poultry vaccine
CA852189A (en) Water-in-oil emulsion vaccine
IL36316A0 (en) Sulfone compositions useful against marek's disease
CA855250A (en) Manufacture of 1-isopropylamino-2-hydroxy-3-(2'-isopropoxy-phenoxy)-propane
CA850625A (en) Preparation of rubella vaccine
AU452255B2 (en) Immunizing vaccine for immunization of dogs against kennel cough
CA835422A (en) Preparation of 4,4'-biphenyldisulfonic acid
IE35139B1 (en) Poultry vaccine
IT1043845B (it) Procedimento per la preparazione di i alohil 2 amminometilpirro lifine
CA837652A (en) Preparation of trihydrocarbyl- and tri-(trifluoropropyl)-silanols